Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 50)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A DDS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 Pechala's Reports Lubomir Pechala DILLARDS INC (DDS=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for RETAILING - GOODS 18 $49 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
9-Feb-10 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (DDS). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (DDS). 5 $18 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Apparel & Textiles Industry Trends & Statistics 2009 (Summary) 52 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Retail Industry Almanac 2010 672 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Retail Industry Trends & Statistics 2010 (Summary) 58 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Apparel & Textiles Industry Market Research and Competitive Analysis 2009 512 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Dillards, Inc. (DDS) Profile & Retail Industry Trends Analysis 2010 40 $149 View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
4-Feb-10 Dundee Securities Corporation David Martin Labopharm Inc. - Once-daily Trazodone Approved 3 $10 View Abstract
4-Feb-10 Dundee Securities Corporation Dundee Research Dundee Wake Up Call - February 4 20 $50 View Abstract
3-Feb-10 Versant Partners Douglas Loe IncreasingLabopharm's target on the back of FDA approval 6 $25 View Abstract

Independent Reports (Showing 1 to 10 of 47)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A DDS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 Pechala's Reports Lubomir Pechala DILLARDS INC (DDS=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for RETAILING - GOODS 18 $49 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
9-Feb-10 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (DDS). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (DDS). 5 $18 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Apparel & Textiles Industry Trends & Statistics 2009 (Summary) 52 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Retail Industry Almanac 2010 672 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Retail Industry Trends & Statistics 2010 (Summary) 58 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Apparel & Textiles Industry Market Research and Competitive Analysis 2009 512 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Dillards, Inc. (DDS) Profile & Retail Industry Trends Analysis 2010 40 $149 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.